ALLO vs CB · rev $22.0K vs P/E 14, rev $59.40B
Allogene Therapeutics Inc (ALLO) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
ALLO currently screens at market cap $258.1M. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the ALLO and CB stock pages for the full models.
Not investment advice.